Skip to content

Clinical Efficacy of Cryolipolysis on the Fat of Thigh in Korean Women

Clinical Efficacy of Local Fat Reduction on the Thigh of Korean Women Through Cryolipolysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01177787
Enrollment
28
Registered
2010-08-09
Start date
2010-07-01
Completion date
2010-10-30
Last updated
2021-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cryotherapy Effect, Lipolysis

Keywords

cryolipolysis, fat, thigh, Korean women

Brief summary

The aim of this study is to evaluate the clinical efficacy of reduction of local fat on ipsilateral thigh through cryolipolysis (zeltiq) and controlateral thigh using by amplitude modulated frequency (conventional) method.

Detailed description

Cryolipolysis is a new concept to reduce fat since Zeltiq machine had been introduced several years ago. Several different trials such as high frequency, liposuction and chemical lipolysis to remove fat had been emerged and tried. Therefore, we would like to know the clinical efficacy of cryolipolysis through comparative experiment with former frequency method on each thigh on healthy Korean women. Healthy premenopausal women who want to reduce the fat on thigh were included. 28 healthy volunteered women recruited for this study, 15 subjects among participated after interviewing, sampling their metabolic variables at initial visit. A total of 15 subjects would be investigated through food diary(24hour), femoral CT, anthropometric, metabolic variables at initial, 4th, 12th week. Histological examination under skin(initial and 12th week), questionnaire(4th, 12th week) for satisfaction, adverse events would be monitored during 3 month.

Interventions

DEVICEzeltiq

Cryolipolysis had been conducted for targeted fat area on thigh for 1 hour through Zeltiq machine made in Zeltiq Aesthetics.

DEVICEelectrical stimulation

Lipolysis would be done on controlateral thigh for 30 minutes through 3000 Hz- amplitude modulated frequency.

Sponsors

Wonik Trade Company, Korea
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* premenopausal healthy women * subjects with body mass index \>= 18. * subjects with visible fat on both thigh * subjects to understand and agree to this study protocol

Exclusion criteria

* subjects with cryoglobulinemia, cold urticaria, or paroxysmal cold hemogobulinemia * subjects with pregnancy or lactation within 6 months or next 3 months * subjects with any laboratory, or metabolic abnormalities * uncooperative subjects to comply with the study protocol * women taking any medication over 6 months * subjects with menstrual irregularities * subjects to change over 10% of the former weight within the past 6 months - any procedure such as liposuction, or another surgical procedure or mesotherapy to reduce fat within 6 months * subjects with any dermatologic abnormalities on the target area (thigh) * subjects with any injection into the area of intended treatment (e.g. cortisone) within 6 months

Design outcomes

Primary

MeasureTime frameDescription
Change in Cross Sectional Area of Fat in Both Thighs4 weeksreduction of fat amounts on both thighs measured by computerizing tomography
Change of the Girths in Both Thighs4 weeksMean differences of the circumferences of both thighs measured by inches

Secondary

MeasureTime frameDescription
Change of the Fat Amount of Both Thighs Between Baseline and 12 Weeksbaseline and 12 weeksThe mean differences of the Cross-Sectional Areas of both Thighs between Baseline and 12 weeks
Change of Girths in Both Thighs for 12 Weeks12 weeksComparison of circumferences of both thighs for 12 weeks
Weight Change for 12 Weeksbaseline and 12 weeksChange in weight for 12 weeks

Countries

South Korea

Participant flow

Pre-assignment details

Two arm, but same group. Electrical Stimulation on Rt thigh versus Zeltiq Application on Left thigh.

Participants by arm

ArmCount
Zeltiq on Left/Electrical Stimulation on Rt
Cryolipolysis had been done for 1 hour on ipsilateral thigh fat through Zeltiq machine. zeltiq: Cryolipolysis had been conducted for targeted fat area on thigh for 1 hour through Zeltiq machine made in Zeltiq Aesthetics. Lipolysis had been done for 30 minutes on controlateral thigh fat through amplitude modulated frequency. electrical stimulation: Lipolysis would be done on controlateral thigh for 30 minutes through 3000 Hz- amplitude modulated frequency.
14
Total14

Withdrawals & dropouts

PeriodReasonFG000
Cryolipolysis on ThighLack of Efficacy9
Cryolipolysis on ThighLost to Follow-up1
Cryolipolysis on ThighProtocol Violation4

Baseline characteristics

CharacteristicZeltiq on Left/Electrical Stimulation on Rt
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
14 Participants
Age, Continuous28.57 years
STANDARD_DEVIATION 7.81
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
14 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
South Korea
14 participants
Sex: Female, Male
Female
14 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 140 / 14
other
Total, other adverse events
4 / 140 / 14
serious
Total, serious adverse events
0 / 140 / 14

Outcome results

Primary

Change in Cross Sectional Area of Fat in Both Thighs

reduction of fat amounts on both thighs measured by computerizing tomography

Time frame: 4 weeks

Population: Cross sectional areas of both thighs at initial visit

ArmMeasureValue (MEAN)Dispersion
Cross Sectional Area on Left ThighChange in Cross Sectional Area of Fat in Both Thighs-420.25 millimeters squaresStandard Deviation 3099.55
Cross Sectional Area on Right ThighChange in Cross Sectional Area of Fat in Both Thighs-28.53 millimeters squaresStandard Deviation 3526.21
Primary

Change of the Girths in Both Thighs

Mean differences of the circumferences of both thighs measured by inches

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
Cross Sectional Area on Left ThighChange of the Girths in Both Thighs0.043 inchesStandard Deviation 0.0362
Cross Sectional Area on Right ThighChange of the Girths in Both Thighs-0.15 inchesStandard Deviation 0.1558
p-value: 0.503Wilcoxon (Mann-Whitney)
Secondary

Change of Girths in Both Thighs for 12 Weeks

Comparison of circumferences of both thighs for 12 weeks

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Cross Sectional Area on Left ThighChange of Girths in Both Thighs for 12 Weeks-0.45 inchStandard Deviation 0.17
Cross Sectional Area on Right ThighChange of Girths in Both Thighs for 12 Weeks-0.15 inchStandard Deviation 0.29
Secondary

Change of the Fat Amount of Both Thighs Between Baseline and 12 Weeks

The mean differences of the Cross-Sectional Areas of both Thighs between Baseline and 12 weeks

Time frame: baseline and 12 weeks

ArmMeasureValue (MEAN)Dispersion
Cross Sectional Area on Left ThighChange of the Fat Amount of Both Thighs Between Baseline and 12 Weeks1597.8853 mm^2Standard Deviation 155.7977453
Cross Sectional Area on Right ThighChange of the Fat Amount of Both Thighs Between Baseline and 12 Weeks1970.0147 mm^2Standard Deviation 398.15115
Secondary

Weight Change for 12 Weeks

Change in weight for 12 weeks

Time frame: baseline and 12 weeks

ArmMeasureValue (MEAN)Dispersion
Cross Sectional Area on Left ThighWeight Change for 12 Weeks-0.38 KgStandard Deviation 0.81
Cross Sectional Area on Right ThighWeight Change for 12 Weeks-0.38 KgStandard Deviation 0.81

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026